Organogenesis Holdings Inc. · Brief

Next report

2 days

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

2 of 8≥ implied

Nov 12 '24±30.4%▲+28.41%×0.94

Feb 27 '25±49.3%▲+102.28%×2.07

May 8 '25±16.5%▼−42.70%×2.58

Aug 7 '25±40.9%▲+0.77%×0.02

Q3 FY25±50.3%▲+44.73%×0.89

Q1 FY26±35.8%▼−13.24%×0.37

May 7 '26±34.7%▼−6.32%×0.18

Q2 FY26±32.3%▼−22.82%×0.71

quarterimplied−105%0+105%realized×

Q2 FY26±32.3%▼−22.82%×0.71

May '26±34.7%▼−6.32%×0.18

Q1 FY26±35.8%▼−13.24%×0.37

Q3 FY25±50.3%▲+44.73%×0.89

Aug '25±40.9%▲+0.77%×0.02

May '25±16.5%▼−42.70%×2.58

2 older reports

Feb '25±49.3%▲+102.28%×2.07

Nov '24±30.4%▲+28.41%×0.94

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 3

134managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+13.52%change in shares held by the ten largest reporting managers over latest quarter13F · Jun 30 '26

Bear2 of 3

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

15managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

ORGO report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.